These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15810640)

  • 1. Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis.
    Mohamadnejad M; Malekzadeh R; Nasseri-Moghaddam S; Hagh-Azali S; Rakhshani N; Tavangar SM; Sedaghat M; Alimohamadi SM
    Dig Dis Sci; 2005 Mar; 50(3):547-51. PubMed ID: 15810640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients.
    Li YN; Ma H; Zhou L; Zhang J; Guo LP; Li SQ; Qian YQ; Wang BM
    Chin Med J (Engl); 2016 Oct; 129(20):2434-2440. PubMed ID: 27748335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 4. [Histological regression of liver fibrosis with immunosuppressive therapy in autoimmune hepatitis].
    Valera JM; Smok G; Márquez S; Poniachik J; Brahm J
    Gastroenterol Hepatol; 2011 Jan; 34(1):10-5. PubMed ID: 21194803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
    Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia.
    Fallatah HI; Akbar HO; Qari YA
    Saudi J Gastroenterol; 2010; 16(2):95-9. PubMed ID: 20339178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustic Radiation Force Impulse (ARFI) for Fibrosis Staging in Patients with Autoimmune Hepatitis.
    Efe C; Gungoren MS; Ozaslan E; Akbiyik F; Kav T
    Hepatogastroenterology; 2015 May; 62(139):670-2. PubMed ID: 26897951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission.
    Maia JM; Maranhão Hde S; Sena LV; Rocha LR; Medeiros IA; Ramos AM
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):264-9. PubMed ID: 20009940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.
    Feld JJ; Dinh H; Arenovich T; Marcus VA; Wanless IR; Heathcote EJ
    Hepatology; 2005 Jul; 42(1):53-62. PubMed ID: 15954109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
    Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
    J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune hepatitis in children in Eastern Denmark.
    Vitfell-Pedersen J; Jørgensen MH; Müller K; Heilmann C
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):376-9. PubMed ID: 22644464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.
    Zachou K; Gatselis NK; Arvaniti P; Gabeta S; Rigopoulou EI; Koukoulis GK; Dalekos GN
    Aliment Pharmacol Ther; 2016 May; 43(10):1035-47. PubMed ID: 26991238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcome of autoimmune liver disease in Asian children.
    Lee WS; Lum SH; Lim CB; Chong SY; Khoh KM; Ng RT; Teo KM; Boey CC; Pailoor J
    Hepatol Int; 2015 Apr; 9(2):292-302. PubMed ID: 25788179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: A cohort study.
    Borssén ÅD; Palmqvist R; Kechagias S; Marschall HU; Bergquist A; Rorsman F; Weiland O; Verbaan H; Nyhlin N; Nilsson E; Werner M
    Medicine (Baltimore); 2017 Aug; 96(34):e7708. PubMed ID: 28834875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis.
    Dhaliwal HK; Anderson R; Thornhill EL; Schneider S; McFarlane E; Gleeson D; Lennard L
    Hepatology; 2012 Oct; 56(4):1401-8. PubMed ID: 22488741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
    Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey.
    Joshita S; Yoshizawa K; Umemura T; Ohira H; Takahashi A; Harada K; Hiep NC; Tsuneyama K; Kage M; Nakano M; Kang JH; Koike K; Zeniya M; Yasunaka T; Takaki A; Torimura T; Abe M; Yokosuka O; Tanaka A; Takikawa H;
    J Gastroenterol; 2018 Sep; 53(9):1079-1088. PubMed ID: 29476251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worse fibro-inflammatory activity on diagnostic liver biopsy adversely impacts biochemical remission in autoimmune hepatitis.
    Khonde P; Choudhury S; Spies NC; Naz N; Stoll J; Fleckenstein J; He M; Ballentine S; Kulkarni S
    Clin Res Hepatol Gastroenterol; 2024 Oct; 48(8):102442. PubMed ID: 39103121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.